Iovance Biotherapeutics, Inc.
Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.
925 employees · est. 2007 · San Carlos, United States
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
4013 employees · est. 2009 · Santa Monica, United States
Iovance Biotherapeutics, Inc. is the older company (2007 vs 2009); Kite Pharma is the larger of the two.
Side-by-Side Comparison
| Metric | Iovance Biotherapeutics, Inc. | Kite Pharma |
|---|---|---|
| Founded | ||
| Founded | 2007 older | 2009 |
| Headquarters | ||
| Headquarters | San Carlos, United States | Santa Monica, United States |
| Employees | ||
| Employees | 925 | 4013 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | Acquired |
| Total Funding | ||
| Total Funding | $1.78B | $12.56B |
| Funding Rounds | ||
| Funding Rounds | 10 | 8 |
| Services | ||
| Services | TIL Therapy Development, Clinical Research, Manufacturing at Cell Therapy Center, Scientific Publications & Presentations, Pipeline Development for Advanced Solid Tumor Cancers | Cell Therapy Development, Manufacturing of CAR T-cell Therapies, Clinical Trials and Research, Patient Support and Resources, External Research Programs |
| Target Customers | ||
| Target Customers | Patients with Advanced Solid Tumor Cancers, Healthcare Providers, Clinical Researchers, Pharmaceutical Investors | Cancer Patients, Healthcare Providers, Research Institutions, Biopharmaceutical Investors, Oncology Care Centers |
| Taxonomy | ||
| Taxonomy | Patient-Centric Organization, Cancer Treatment Innovation, Tumor Infiltrating Lymphocytes (TIL) Therapy, Autologous T-Cell Treatment, Immunotherapy Development, Solid Tumor Focus, Gene-Edited Cell Therapy, Cell Therapy Manufacturing, Clinical Data Development, Regulatory Approval Preparation, San Francisco Bay Area Headquarters, Philadelphia Manufacturing Facility, Tampa Research Site, Commercial Launch Execution, Cancer Immunotherapy Commercialization | Cell Therapy, Cancer Immunotherapy, Hematologic Malignancies, Engineered T Cell Therapy, Autologous Cell Therapy, Immune-Based Targeted Therapies, Tumor Cell Reengineering, Cancer Treatment Innovation, Patient-Specific Treatments, Biopharmaceutical Manufacturing, T Cells Engineering, Oncology Therapeutics, Immune System Stimulation |
| Website | ||
| Website | iovance.com | kitepharma.com |
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is a biotechnology company founded in 2007 with a mission to revolutionize cancer treatment through its innovative tumor infiltrating lymphocyte (TIL) therapies. As a patient-centric organization, Iovance harnesses the human immune system's potential to target and elimi...
About Kite Pharma
Kite Pharma, a subsidiary of Gilead Sciences, is a pioneering company in the Biotechnology, Health Care, and Health and Wellness industries, renowned for its commitment to cell therapy as a remedy for cancer. Founded in 2009, Kite has positioned itself as a leader in engineered T cell therapy for he...
We will tell you when either one moves
BounceWatch watches Iovance Biotherapeutics, Inc. and Kite Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Iovance Biotherapeutic... and Kite Pharma — by email.
Frequently Asked Questions
Compare Iovance Biotherapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Iovance Biotherapeutics, Inc. on 9 Jun 2026, and Kite Pharma on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
